Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha
about
Molecular analysis of thymopentin binding to HLA-DR moleculesThe instructive role of dendritic cells on T-cell responsesRNA vaccines in cancer treatmentGABAergic signaling is linked to a hypermigratory phenotype in dendritic cells infected by Toxoplasma gondiiThe intestinal archaea Methanosphaera stadtmanae and Methanobrevibacter smithii activate human dendritic cellsOrganic dust exposure alters monocyte-derived dendritic cell differentiation and maturationA dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin (DC-SIGN)-related protein is highly expressed on human liver sinusoidal endothelial cells and promotes HIV-1 infectionCharacterization of human palladin, a microfilament-associated proteinA DAP12-mediated pathway regulates expression of CC chemokine receptor 7 and maturation of human dendritic cellsHeat shock proteins 70 and 60 share common receptors which are expressed on human monocyte-derived but not epidermal dendritic cellsToll-like receptor 3 associates with c-Src tyrosine kinase on endosomes to initiate antiviral signalingA common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cellsCystatin F is a cathepsin C-directed protease inhibitor regulated by proteolysisRole of annexins in endocytosis of antigens in immature human dendritic cellsToll-like receptor 2 (TLR2) and TLR4 are present inside human dendritic cells, associated with microtubules and the Golgi apparatus but are not detectable on the cell surface: integrity of microtubules is required for interleukin-12 production in reA novel inhibitory receptor (ILT3) expressed on monocytes, macrophages, and dendritic cells involved in antigen processingHuman macrophage-derived chemokine (MDC), a novel chemoattractant for monocytes, monocyte-derived dendritic cells, and natural killer cellsPolymerase chain reaction selects a novel disintegrin proteinase from CD40-activated germinal center dendritic cellsCD83 is preformed inside monocytes, macrophages and dendritic cells, but it is only stably expressed on activated dendritic cellsCharacterization of MAX.3 antigen, a glycoprotein expressed on mature macrophages, dendritic cells and blood platelets: identity with CD84Activating and inhibitory IgG Fc receptors on human DCs mediate opposing functionsMinor histocompatibility antigen DBY elicits a coordinated B and T cell response after allogeneic stem cell transplantationFunctional evaluation of DC-SIGN monoclonal antibodies reveals DC-SIGN interactions with ICAM-3 do not promote human immunodeficiency virus type 1 transmissionActivation of terminally differentiated human monocytes/macrophages by dengue virus: productive infection, hierarchical production of innate cytokines and chemokines, and the synergistic effect of lipopolysaccharideMedical immunology: a new journal for a new subspecialty.Selective up-regulation of PDE1B2 upon monocyte-to-macrophage differentiationPlasmacytoid dendritic cells: linking innate and adaptive immunityA series of diaryltriazines and diarylpyrimidines are highly potent nonnucleoside reverse transcriptase inhibitors with possible applications as microbicidesHuman IL-23-producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco)bacteriaMicroRNA-155 modulates the pathogen binding ability of dendritic cells (DCs) by down-regulation of DC-specific intercellular adhesion molecule-3 grabbing non-integrin (DC-SIGN)CCR6, a CC chemokine receptor that interacts with macrophage inflammatory protein 3alpha and is highly expressed in human dendritic cellsLigation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activationDendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial productsHow can cryptic epitopes trigger autoimmunity?Stimulatory and inhibitory effects of interleukin (IL)-4 and IL-13 on the production of cytokines by human peripheral blood mononuclear cells: priming for IL-12 and tumor necrosis factor alpha productionCommunicable ulcerative colitis induced by T-bet deficiency in the innate immune systemDetection of anaphylatoxin receptors on CD83+ dendritic cells derived from human skinLatent membrane protein 1 of Epstein-Barr virus induces CD83 by the NF-kappaB signaling pathwayDendritic cells: In the forefront of immunopathogenesis and vaccine development - A reviewFlt3+ macrophage precursors commit sequentially to osteoclasts, dendritic cells and microglia.
P2860
Q21092228-DE8CFF24-38E1-43B6-87C9-940F051B6877Q21195249-5013F97B-771E-4C78-AEB5-3507E2AAB747Q21296852-F1168F7F-B702-4763-BEDE-C18EE6B368EEQ21558782-42F44088-497A-41E1-A9C2-2FC11E6BE6A6Q21559458-E0759B51-776D-44A8-BB22-E306C71CDFF9Q23914902-31F42A04-643C-40DE-A294-8F4883F8D7EFQ24290940-EE80C633-A58A-43BE-AB12-F827ED01C41EQ24291793-9D48C528-A2A5-4D36-B298-8D2EA12328F2Q24291798-EBBB1D58-306F-4B3B-B233-8B39CAF407EFQ24292217-67D6ED32-46FB-4B6B-98D2-68A7207D7871Q24297831-813B8038-50D5-4AF2-8760-E7C3E49E223EQ24310017-F3F55EDC-E9B3-4C52-81BF-EF3E3995754FQ24311722-783F1589-9597-4981-8615-C6F6CE7A4BB4Q24316546-4BDEF774-4E4F-4233-8F79-0798A6E2A73CQ24317455-46A0E9B3-DED8-452C-84B7-4BB81A52D1C4Q24321561-BA58850C-14BF-48ED-A50B-3B2243298293Q24321607-D559ED79-AA89-49CF-82B1-26B1144C9953Q24336346-05DC5DE7-C19E-4899-A3CC-7A215C7F5284Q24528149-AF79FC04-D42D-4A29-9D25-4517F2AB3DDEQ24531986-A48D2AE6-C7EF-4795-B83C-775C14BED3FCQ24532135-27600F79-514E-47EC-8EF9-43A5A00EA1E2Q24537575-18F27460-0546-4655-A4F7-4317AEFC70EFQ24537674-7601684C-62CB-4878-A7AE-3D7CF20F06ACQ24538617-3FED90C7-FEE3-4BFD-85A3-262497544C90Q24538980-62AA823F-C8F6-44AB-81A1-34AF0481B93CQ24557526-EA51007D-8662-4C0D-80CD-7564063F393DQ24558695-E1C72372-6665-4104-B7F4-DA721CD6A3F2Q24563844-FEBB7B0D-D680-41C0-93CC-B75FC4775CFFQ24633691-F9D8EDB8-E42A-4D3A-8E28-8FBBF63206E3Q24647119-63CB25A8-358E-44B6-9E92-0556106F0E4DQ24652932-0B37113A-3595-44BD-8350-F116F68C740FQ24677534-C0A2ECE7-05B5-45A5-8956-6D73235E0E4EQ24678867-6820C282-C66D-47A6-B7E3-C1EDFF081E89Q24678950-D37DE786-B1CD-4932-AC6B-7A0D168B0DCDQ24679477-99CB5D52-84B4-4935-9C72-911E04539E7CQ24680733-3F8A141F-F155-4520-8FDB-734A0E5EA15DQ24682489-D468D598-1656-4133-985D-45BFCCF0417CQ24682515-BB0AB622-A84B-444D-943E-77CE6776C88BQ24792153-3FA1F8B5-20F7-4423-B9AF-F022A8265A5BQ24794597-DB1382AD-13CA-4CCA-B506-92A87B3B9C7F
P2860
Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha
description
1994 nî lūn-bûn
@nan
1994 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Efficient presentation of solu ...... by tumor necrosis factor alpha
@ast
Efficient presentation of solu ...... by tumor necrosis factor alpha
@en
Efficient presentation of solu ...... by tumor necrosis factor alpha
@nl
Excultus, humanae cellulis per ...... factor Alpha et downregulated
@la
type
label
Efficient presentation of solu ...... by tumor necrosis factor alpha
@ast
Efficient presentation of solu ...... by tumor necrosis factor alpha
@en
Efficient presentation of solu ...... by tumor necrosis factor alpha
@nl
Excultus, humanae cellulis per ...... factor Alpha et downregulated
@la
prefLabel
Efficient presentation of solu ...... by tumor necrosis factor alpha
@ast
Efficient presentation of solu ...... by tumor necrosis factor alpha
@en
Efficient presentation of solu ...... by tumor necrosis factor alpha
@nl
Excultus, humanae cellulis per ...... factor Alpha et downregulated
@la
P2860
P3181
P356
P1476
Efficient presentation of solu ...... by tumor necrosis factor alpha
@en
P2093
A Lanzavecchia
F Sallusto
P2860
P304
P3181
P356
10.1084/JEM.179.4.1109
P407
P577
1994-04-01T00:00:00Z